Research suggests that stinging nettle (Urtica dioica) may support blood sugar regulation through several complementary mechanisms, including reducing blood glucose levels, influencing insulin-related signaling pathways such as GSK-3 beta, and improving markers of metabolic health. The available evidence consists of a narrative review of literature from 1990 to 2021, two animal studies using streptozotocin-induced diabetic rat models, and one very small human trial involving sixteen participants using a multi-herb combination product rather than nettle alone — all pointing in a supportive direction, though none constitute large-scale randomized controlled trials in humans. Studies indicate that these findings, while consistently encouraging, carry significant limitations: the animal research may not translate directly to human outcomes, the one human trial was too small and insufficiently controlled to draw firm conclusions, and the multi-ingredient formulation used in that trial makes it difficult to isolate nettle's specific contribution. Taken together, the body of evidence is preliminary and suggestive rather than conclusive, and larger, well-designed human trials would be needed before stronger claims about stinging nettle's role in blood sugar management could be made.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Anti-diabetic potential of Urtica Dioica: current knowledge and future direct... | Review | 2022 | Supports | 72 |
| Exercise and Urtica Dioica extract ameliorate mitochondrial function and the ... | Other | 2022 | Supports | 67 |
| Urtica Dioica and Lamium Album Decrease Glycogen Synthase Kinase-3 beta and I... | Other | 2019 | Supports | 62 |
| Maintaining a physiological blood glucose level with 'glucolevel', a combinat... | Other | 2008 | Supports | 57 |